Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,122.17
    +630.68 (+0.72%)
     

  • CMC Crypto 200

    1,385.99
    +73.36 (+5.59%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

New Strong Sell Stocks for November 16th

Zacks Equity Research
·1 min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Eldorado Gold EGO is a gold producing and exploration company with gold assets in Brazil and Turkey. The Zacks Consensus Estimate for its current year earnings has been revised almost 76.9% downward over the last 60 days.

BRF BRFS is a Brazil-based food company focused on the production and sale of poultry, pork, beef cuts, milk, dairy products, and processed food products. The Zacks Consensus Estimate for its current year earnings has been revised 59.0% downward over the last 60 days.

Amryt Pharma AMYT is a biopharmaceutical company that develops and commercializes therapeutics to treat rare diseases. The Zacks Consensus Estimate for its current year earnings has been revised 47.1% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BRF S.A. (BRFS) : Free Stock Analysis Report
 
Eldorado Gold Corporation (EGO) : Free Stock Analysis Report
 
Amryt Pharma PLC Sponsored ADR (AMYT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research